Esketamine and remimazolam Clinical Trials

1 actively recruiting trial

Also known as: Patients undergoing gastroenteroscopies were given propofol 2 to 3mg/kg， esketamine 0.2mg/kg and remimazolam 0.15mg/kg before the procedure began

Filter by location:

Other1 trial

Esketamine Combined With Remimazolam on Postoperative Sleep Disturbance and Anxiety in Patients

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.